A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Tuesday, January 24 | 12-1 pm ET | Virtual DCRI Research Forum: Unlocking the Promise of Gene Therapy Peter Marks, MD, PhD Director, Center for Biologics Evaluation and Research U.S. Food and Drug Administration Register for the DCRI Research Forum
Thursday, June 22 | 2-3 p.m. ET | Online Although relatively new in terms of clinical application, several gene therapy-based treatments have, in recent years, received approval from the Food and Drug Administration (FDA) and begun to be used in real world settings in the United States. In addition, clinical trials using either gene transfer […]
2025 ACMG Annual Clinical Genetics Meeting March 18 – 22 | Los Angeles, California The 2025 ACMG Annual Clinical Genetics Meeting will gather members of the medical genetics community from around the world to learn, connect and celebrate together in Los Angeles, California. This four-day meeting offers unique and valuable opportunities to forge meaningful connections, […]
GMKB